The New Reality of Peptide Analysis
June 15, 2026
Kelly Broster of Thermo Fisher Scientific explains why GLP-1 peptides are exposing the limits of traditional analytical workflows
6 min read
False
June 15, 2026
Kelly Broster of Thermo Fisher Scientific explains why GLP-1 peptides are exposing the limits of traditional analytical workflows
6 min read
June 10, 2026
Antibody-drug conjugates are transforming cancer care, but their success depends on more precise, sensitive, and data-driven diagnostics
13 min read
June 9, 2026
Ahead of ISC2026 in Prague, Koen Sandra explores how analytical scientists are rising to the challenge posed by increasingly intimidating biotherapeutics
11 min read
June 8, 2026
As vaccine technologies continue to expand, David Hage explores how analytical methods must evolve to meet growing demands for safety, quality, and activity testing
9 min read
By James Strachan
May 25, 2026
Bristol Myers Squibb’s Robert Wethman discusses real-time spectroscopy, AI, and the next era of biopharmaceutical manufacturing
5 min read
By James Strachan
May 8, 2026
Ahead of HPLC 2026, Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients
11 min read
April 28, 2026
Patient-derived tumor explants reveal uneven PARP inhibitor uptake, with lysosomes acting as reservoirs for some weak-base drugs
3 min read
April 14, 2026
ICP-MS method enables early, quantitative metabolite analysis without radiolabels
2 min read
April 14, 2026
Experts explore how analytical science is meeting the challenges shaping GLP-1 therapeutics
1 min read
April 13, 2026
Comprehensive review highlights label-free viral detection – and the hurdles to real-world deployment
2 min read
False
False
Affiliations:
Specialties:
Areas of Expertise:
False